Company intelligence / Profile preview

Seoul Clinical Laboratories

Yongin-si, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

Seoul Clinical Laboratories is the largest clinical and diagnostic laboratory service provider in Korea, with College of American Pathologists (CAP) accreditation, delivering over 4,500 medical tests including specialized molecular, genomic and pathology diagnostics; their ASAP algorithm has shown improved sensitivity for early liver cancer detection compared to standard AFP testing, and SCL is expanding its digital health, AI diagnostics, and international capabilities.

Therapeutic areas: GastroenterologyOncologyOtherPulmonology
Industry: Molecular Diagnostics

Partnerships

Gangnam Severance Hospital (for critical overseas respiratory failure patients)H2U (digital health in Taiwan and cross-border AI health data platforms)

Beyond the preview

Go deeper on Seoul Clinical Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seoul Clinical Laboratories.

Explore the full profile